{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:29:27Z","timestamp":1786465767167,"version":"build-2736575974"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,11]]},"DOI":"10.7759\/cureus.114347","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:12:10Z","timestamp":1786461130000},"source":"Crossref","is-referenced-by-count":0,"title":["Mucocutaneous Hyperpigmentation as the Diagnostic Clue to Autoimmune Polyglandular Syndrome Type 2: A Case Report"],"prefix":"10.7759","author":[{"given":"Pedro","family":"Reboredo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye ES","year":"2018","unstructured":"Husebye ES, Anderson MS, K\u00e4mpe O. Autoimmune polyendocrine syndromes. N Engl J Med. 2018, 378:1132-41. 10.1056\/NEJMra1713301","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye ES","year":"2021","unstructured":"Husebye ES, Pearce SH, Krone NP, K\u00e4mpe O. Adrenal insufficiency. Lancet. 2021, 397:613-29. 10.1016\/S0140-6736(21)00136-7","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12162","article-title":"Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency","volume":"275","author":"Husebye ES","year":"2014","unstructured":"Husebye ES, Allolio B, Arlt W, et al.. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med. 2014, 275:104-15. 10.1111\/joim.12162","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Bornstein SR","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, et al.. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016, 101:364-89. 10.1210\/jc.2015-1710","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e3181db6b7a","article-title":"Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients","volume":"339","author":"Bleicken B","year":"2010","unstructured":"Bleicken B, Hahner S, Ventz M, Quinkler M. Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci. 2010, 339:525-31. 10.1097\/MAJ.0b013e3181db6b7a","journal-title":"Am J Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1285901","article-title":"Autoimmune primary adrenal insufficiency -current diagnostic approaches and future perspectives","volume":"14","author":"Wolff AS","year":"2023","unstructured":"Wolff AS, Kucuka I, Oftedal BE. Autoimmune primary adrenal insufficiency -current diagnostic approaches and future perspectives. Front Endocrinol (Lausanne). 2023, 14:1285901. 10.3389\/fendo.2023.1285901","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092080","article-title":"New approach to Addison disease: oral manifestations due to endocrine dysfunction and comorbidity burden","volume":"12","author":"Bug\u0103l\u0103 NM","year":"2022","unstructured":"Bug\u0103l\u0103 NM, Carsote M, Stoica LE, et al.. New approach to Addison disease: oral manifestations due to endocrine dysfunction and comorbidity burden. Diagnostics (Basel). 2022, 12:2080. 10.3390\/diagnostics12092080","journal-title":"Diagnostics (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.40","article-title":"Autoimmune polyglandular syndromes","volume":"6","author":"Michels AW","year":"2010","unstructured":"Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol. 2010, 6:270-7. 10.1038\/nrendo.2010.40","journal-title":"Nat Rev Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/518282-mucocutaneous-hyperpigmentation-as-the-diagnostic-clue-to-autoimmune-polyglandular-syndrome-type-2-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:12:11Z","timestamp":1786461131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/518282-mucocutaneous-hyperpigmentation-as-the-diagnostic-clue-to-autoimmune-polyglandular-syndrome-type-2-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.114347","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}